Wealth Architects, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 275 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Wealth Architects, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$314,739
-9.1%
12,1100.0%0.04%
-17.4%
Q1 2024$346,346
-6.5%
12,1100.0%0.05%
-11.5%
Q4 2023$370,566
+13.1%
12,110
-0.7%
0.05%
-7.1%
Q3 2023$327,787
-24.6%
12,1990.0%0.06%
-22.2%
Q2 2023$435,016
+12.7%
12,199
-19.7%
0.07%
+5.9%
Q1 2023$386,055
-37.4%
15,1990.0%0.07%
-41.9%
Q4 2022$616,471
+20.6%
15,199
-1.6%
0.12%
+9.3%
Q3 2022$511,000
-6.1%
15,4480.0%0.11%
+0.9%
Q2 2022$544,000
-23.5%
15,448
-0.0%
0.11%
-12.4%
Q1 2022$711,000
-30.6%
15,4530.0%0.12%
-32.8%
Q4 2021$1,025,000
+6.2%
15,4530.0%0.18%
-3.7%
Q3 2021$965,000
-24.6%
15,4530.0%0.19%
-25.5%
Q2 2021$1,280,000
+27.9%
15,453
+2.4%
0.25%
+15.7%
Q1 2021$1,001,000
-13.6%
15,0890.0%0.22%
-19.3%
Q4 2020$1,158,000
+78.2%
15,0890.0%0.27%
+52.8%
Q3 2020$650,000
-0.3%
15,0890.0%0.18%
-3.8%
Q2 2020$652,000
+50.2%
15,0890.0%0.18%
+21.2%
Q1 2020$434,000
-54.6%
15,0890.0%0.15%
-43.4%
Q4 2019$957,000
+126.2%
15,089
+0.6%
0.27%
+107.0%
Q3 2019$423,000
+59.6%
15,000
+50.0%
0.13%
+61.2%
Q2 2019$265,000
+44.0%
10,0000.0%0.08%
+40.4%
Q1 2019$184,000
+48.4%
10,0000.0%0.06%
+26.7%
Q4 2018$124,00010,0000.04%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2024
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$93,815,00051.06%
Aquilo Capital Management, LLC 436,514$12,559,0004.90%
Vivo Capital, LLC 768,674$22,115,0002.00%
ACUTA CAPITAL PARTNERS, LLC 109,700$3,156,0001.53%
Prosight Management, LP 104,737$3,013,0001.41%
Capital Impact Advisors, LLC 84,537$2,432,0001.02%
Artal Group S.A. 600,000$17,262,0000.73%
HUSSMAN STRATEGIC ADVISORS, INC. 62,000$1,784,0000.48%
Quantitative Investment Management, LLC 150,401$4,327,0000.47%
OAK RIDGE INVESTMENTS LLC 131,502$3,784,0000.39%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders